Nuritas has raised €40m ($45m) in the Irish biotech firm’s latest round of funding intended to finance global expansion efforts and potential new additions to its portfolio of plant-based bioactive peptides.
Nuritas has raised €40m ($45m) in the Irish biotech firm’s latest round of funding intended to finance global expansion efforts and potential new additions to its portfolio of plant-based bioactive peptides.